CN112402414B - Medicine for preventing and treating animal ectoparasitosis and application thereof - Google Patents
Medicine for preventing and treating animal ectoparasitosis and application thereof Download PDFInfo
- Publication number
- CN112402414B CN112402414B CN201911304065.4A CN201911304065A CN112402414B CN 112402414 B CN112402414 B CN 112402414B CN 201911304065 A CN201911304065 A CN 201911304065A CN 112402414 B CN112402414 B CN 112402414B
- Authority
- CN
- China
- Prior art keywords
- methoxy
- chromene
- group
- chromen
- ketone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 241001465754 Metazoa Species 0.000 title claims abstract description 27
- 229940079593 drug Drugs 0.000 title claims abstract description 23
- MLCMXDYMSAZNPC-UHFFFAOYSA-N 4-methoxychromen-2-one Chemical compound C1=CC=CC2=C1OC(=O)C=C2OC MLCMXDYMSAZNPC-UHFFFAOYSA-N 0.000 claims abstract description 26
- 244000078703 ectoparasite Species 0.000 claims abstract description 17
- 208000029639 Ectoparasitic disease Diseases 0.000 claims abstract 3
- 208000030852 Parasitic disease Diseases 0.000 claims abstract 3
- 241000238876 Acari Species 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000749 insecticidal effect Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 239000002904 solvent Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- 239000000575 pesticide Substances 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940126672 traditional medicines Drugs 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 14
- GUAFOGOEJLSQBT-UHFFFAOYSA-N scoparone Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 10
- 241000255925 Diptera Species 0.000 description 9
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 7
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 7
- IGWDEVSBEKYORK-UHFFFAOYSA-N isoimperatorin Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)C IGWDEVSBEKYORK-UHFFFAOYSA-N 0.000 description 7
- 229960002418 ivermectin Drugs 0.000 description 7
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 6
- 206010000351 Acariasis Diseases 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 230000000895 acaricidal effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000002266 mite infestation Diseases 0.000 description 6
- GSFDOOHGKOHDEL-UHFFFAOYSA-N Dalpanitin Natural products COc1cc(ccc1O)C2=COc3c(C4OC(CO)C(O)C(O)C4O)c(O)cc(O)c3C2=O GSFDOOHGKOHDEL-UHFFFAOYSA-N 0.000 description 5
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 5
- SVHDRHWULLNMQC-UHFFFAOYSA-N scoparone Natural products C1=CC(=O)OC2=C1C=C(C(=O)C)C(C(C)=O)=C2 SVHDRHWULLNMQC-UHFFFAOYSA-N 0.000 description 5
- -1 4-methoxy-2H-chromen-2-one compound Chemical class 0.000 description 4
- 231100000225 lethality Toxicity 0.000 description 4
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 3
- 241001674048 Phthiraptera Species 0.000 description 3
- 241000258242 Siphonaptera Species 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- 150000004775 coumarins Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 3
- ZPSAEGUNYMEKBP-UHFFFAOYSA-N 5-Isopentenyloxy-psoralen Natural products CC(C)C=COc1c2C=CC(=O)Oc2cc3occc13 ZPSAEGUNYMEKBP-UHFFFAOYSA-N 0.000 description 2
- BEYIWVKWKJROGZ-UHFFFAOYSA-N Alloimperatorin Natural products O1C(=O)C=CC2=C1C(O)=C1OC=CC1=C2OCC=C(C)C BEYIWVKWKJROGZ-UHFFFAOYSA-N 0.000 description 2
- KGGUASRIGLRPAX-UHFFFAOYSA-N Meranzin hydrate Natural products C1=CC(=O)OC2=C(CC(O)C(C)(C)O)C(OC)=CC=C21 KGGUASRIGLRPAX-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002611 lead compounds Chemical class 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000505 pernicious effect Effects 0.000 description 2
- 230000001185 psoriatic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012747 synergistic agent Substances 0.000 description 2
- YBEWLMKRCGNUIO-TWGQIWQCSA-N (5z)-5-[(5-methylfuran-2-yl)methylidene]furan-2-one Chemical compound O1C(C)=CC=C1\C=C/1C=CC(=O)O\1 YBEWLMKRCGNUIO-TWGQIWQCSA-N 0.000 description 1
- LJRLROKTSKSKHS-UHFFFAOYSA-N 3-(hydroxymethyl)chromen-2-one Chemical group C1=CC=C2OC(=O)C(CO)=CC2=C1 LJRLROKTSKSKHS-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000007407 African swine fever Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000012004 Ghrelin Human genes 0.000 description 1
- 101800001586 Ghrelin Proteins 0.000 description 1
- 241000179420 Haemaphysalis longicornis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000509427 Sarcoptes scabiei Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- HQCYVSPJIOJEGA-UHFFFAOYSA-N methoxycoumarin Chemical class C1=CC=C2OC(=O)C(OC)=CC2=C1 HQCYVSPJIOJEGA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000723 toxicological property Toxicity 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了化合物4‑甲氧基‑2H‑色烯‑2‑酮作为防治动物外寄生虫病药物的用途。所述的4‑甲氧基‑2H‑色烯‑2‑酮作为杀虫药物与传统的药物相比，具有以下特点和优点：4‑甲氧基‑2H‑色烯‑2‑酮防治动物外寄生虫病效果好，相较于现有技术中的杀虫剂获得了显著提高；4‑甲氧基‑2H‑色烯‑2‑酮其毒性低，对环境安全；4‑甲氧基香豆素能溶于多种溶剂，易与其它杀动物体外寄生虫成分混配制药，可起到提高杀虫效果的作用。本发明提供了一种较为安全的杀动物外寄生虫药物。The invention discloses the use of the compound 4-methoxy-2H-chromene-2-ketone as a medicine for preventing and treating ectoparasitic diseases of animals. Compared with traditional medicines, the 4-methoxy-2H-chromene-2-ketone has the following characteristics and advantages as an insecticidal drug: 4-methoxy-2H-chromene-2-ketone controls animals The ectoparasitic disease effect is good, and compared with the pesticides in the prior art, it has been significantly improved; 4-methoxy-2H-chromene-2-ketone has low toxicity and is safe to the environment; 4-methoxy Coumarin can be dissolved in various solvents, and can be easily mixed with other ectoparasite ingredients for killing animals, which can improve the insecticidal effect. The invention provides a relatively safe animal ectoparasite drug.
Description
Technical Field
The invention belongs to the field of veterinary medicines, and discloses a new application of a 4-methoxy-2H-chromen-2-one compound, in particular to an application of the compound in preventing and treating animal ectoparasitosis.
Background
Animal ectoparasites such as fleas, lice, flies, mosquitoes, ticks, and mites can be infested with many types of animals at all ages, resulting in reduced performance of the affected animals and in decreased quality of the livestock products, and even death. It is reported that the transmission of African swine fever, a virulent infectious disease that severely affects the production of domestic pigs, is inseparable with insects such as ticks as vectors. Meanwhile, the health of human beings is seriously threatened, and 1 to 3 hundred million cases of scabies infection are reported every year in the world. Animal ectoparasitosis not only directly affects the production benefit and healthy development of livestock breeding industry, but also harms related industries such as leather processing and the like, and causes serious economic loss. At present, chemical drugs are still important means for controlling the occurrence of the diseases caused by the external diseases of the animals, such as organic phosphorus, carbamates, pyrethroids and the like, but the problems of drug resistance, drug residues and the like are often generated after long-term use of a large amount of the drugs. Therefore, the development of a high-efficiency, safe and low-toxicity medicament capable of effectively treating animal ectoparasitosis is of great significance.
At present, some medicines for treating animal ectoparasites, such as amido hydroxymethyl coumarins, have been developed to have good acaricidal activity; the methoxy coumarin compounds such as scopoletin and scoparone have good acaricidal activity; coumarin compounds such as imperatorin, isoimperatorin and the like have certain insecticidal activity, but the insecticidal effect of the medicine is not obvious, and the clinical application cannot be met.
4-methoxy-2H-chromen-2-one (4-methoxy-2H-chromen-2-on), CAS: 20280-81-3, molecular formula is C10H8O3. The coumarin compound is derived from microorganisms, can be synthesized, has a simple synthesis method, belongs to coumarin compounds, and has less research on the pharmacological and toxicological properties at present. In the invention, the inventor discovers for the first time that the 4-methoxy-2H-chromen-2-one has good insecticidal and acaricidal activity and can be used for preventing and treating animal ectoparasite diseases.
Disclosure of Invention
The invention aims to provide a new application of 4-methoxy-2H-chromen-2-one. The specific technical scheme is as follows:
the invention aims to provide application of 4-methoxy-2H-chromen-2-one in preparation of a medicine for preventing/treating animal ectoparasite diseases.
Preferably, the animal ectoparasite is one or more of tick, mite, flea, louse, fly and mosquito.
Another object of the present invention is to provide the use of 4-methoxy-2H-chromen-2-one as a synergistic agent against animal ectoparasitic agents.
Preferably, the animal ectoparasite is one or more of tick, mite, flea, louse, fly and mosquito.
The invention also aims to provide application of the 4-methoxy-2H-chromen-2-one serving as a lead compound of an anti-parasitic drug.
Preferably, the animal ectoparasite is one or more of tick, mite, flea, louse, fly and mosquito.
Preferably, the 4-methoxy-2H-chromen-2-one is added with pharmaceutically acceptable auxiliary materials to be prepared into powder, injection, external ointment, emulsion, spray and the like.
The medicine of the invention has the beneficial effects that:
the 4-methoxy-2H-chromene-2-one has high-efficiency prevention and treatment effects on animal ectoparasite diseases, and can be used as a new insecticidal lead compound or a synergistic agent for biological reasonable development. Has better control effect on various common animal ectoparasite diseases such as ticks, mites, fleas, lice, flies, mosquitoes and the like. Experiments prove that the lethality of the 4-methoxy-2H-chromene-2-one to the young ticks longicornus is 75.33 +/-3.06%, and is remarkably improved compared with the pesticide in the prior art. And the cure rate of the 4-methoxy-2H-chromene-2-ketone for treating rabbit acariasis is 86.67%, the total effective rate is 100%, and the treatment effect is equivalent to that of the commercially available ivermectin. The 4-methoxy-2H-chromene-2-ketone is simple to synthesize, can be dissolved in various solvents, is easy to be mixed with other acaricidal components for preparing a medicament, plays a role in improving the acaricidal effect, and is suitable for popularization and application.
Detailed Description
The foregoing and other aspects of the present invention will become more apparent from the following detailed description, given by way of example only, for purposes of illustrating the invention. This is not to be construed as limiting the invention.
The experiments disclosed by the invention are not specially explained, and all adopt a conventional method;
the drugs of the present invention are not specifically described, and are commercially available.
Example 1 study of insecticidal Activity of coumarins on Young Lepidium hunger
1. Experimental methods and materials
Collecting Haemaphysalis longicornis hungericornis starving adult ticks, carrying out passage by using New Zealand big ear white rabbits as hosts, and culturing at 27 +/-2 ℃ under the condition that RH is more than or equal to 80%. The test ticks were used only once and then sacrificed with boiling water.
Grouping experiments: 4-methoxy-2H-chromen-2-one, 7-hydroxy-4-methylcoumarin (hydroxymethyl coumarin) group, scopoletin group, imperatorin group, and isoimperatorin group.
The experimental method comprises the following steps: 50 young ticks incubated for 10 days were placed in filter paper bags of 4X 4cm according to the filter paper bag method. After the drug was dissolved in 10% DMSO, 0.8ml of the drug solution was soaked in filter paper coated with young ticks, and the solvent control was 10% DMSO. After 5 minutes, all young ticks were transferred to untreated filter paper bags, sealed, cultured in an incubator (27. + -. 1 ℃ C., RH. gtoreq.80%) for 24h, counted under a microscope for the number of deaths, and considered dead once immobile. The experiment was performed in triplicate.
2. Results of the experiment
TABLE 1 insecticidal Activity of different compounds on Young ticks hunger
| Group of | Concentration of | Mortality (%) |
| 4-methoxy-2H-chromen-2-one group | 300μg/mL | 75.33±3.06％ |
| 7-hydroxy-4-methylcoumarins | 300μg/mL | 52.00±4.00％ |
| Scopoletin lactone group | 300μg/mL | 32.66±3.06％ |
| Scoparone group | 300μg/mL | 61.33±5.03％ |
| Imperatorin group | 300μg/mL | 31.33±3.06％ |
| Isoimperatorin group | 300μg/mL | 16.00±5.29％ |
| Solvent control group | -- | 0.00±0.00 |
The insecticidal activity of different compounds on young ghrelin ticks is shown in table 1, and it can be seen from table 1 that the highest lethality rate of the 4-methoxy-2H-chromen-2-one group is 75.33 +/-3.06% under the same drug concentration, compared with the 7-hydroxy-4-methylcoumarin group, scopoletin group, imperatorin group, isoimperatorin group and solvent control group, the insecticidal activity of the 4-methoxy-2H-chromen-2-one group is the best. Comparison of the control group of 7-hydroxy-4-methylcoumarin, scopoletin, scoparone, imperatorin and isoimperatorin revealed that the highest lethality of scoparone group was 61.33 ± 5.03%. In order to further verify the insecticidal activity of the 4-methoxy-2H-chromen-2-one, the 4-methoxy-2H-chromen-2-one and scoparone are selected for subsequent mite-killing clinical efficacy research.
EXAMPLE 2 study of the clinical efficacy of acaricidal Agents
1. Experimental groups and dosages
4-methoxy-2H-chromen-2-one drug treatment group: 100 mu g/mL;
the scoparone drug treatment group comprises: 100 mu g/mL;
1% ivermectin group: 100 mu g/mL;
2. experimental methods
New Zealand big-ear white rabbits naturally infected with psoriatic mites are collected from a farm, according to a grading system (table 2) of the conditions of the psoriatic mites clinically infected with rabbits, 45 big-ear white rabbits with similar scores are selected and randomly divided into three groups of 15 rabbits, each group of 15 rabbits is free from other drug treatments and other complications before experiments, and clinically no significant difference exists among the three groups. The 4-methoxy-2H-chromene-2-one drug treatment group and the scoparone drug treatment group spray drugs on the crus of the external auditory canals of the rabbits, and the drugs are respectively administered once every 3 days, 6 days, 9 days, 12 days and 15 days, 2mL for each time, and 5 times, and the ivermectin group is injected according to the drug instruction. Observing the clinical manifestations and health conditions of the rabbits suffering from the acariasis within 15 days, and grading and judging the curative effect according to the diseased situation.
TABLE 2 grading System for clinical itch mite rabbit cases and recovery conditions
3. Results of the experiment
The curative effect of different medicines for treating rabbit acariasis is shown in table 3, and the 4-methoxy-2H-chromene-2-one group obtained from the curative effect for treating rabbit acariasis is 86.67 percent, and the total effective rate is 100 percent; the cure rate of the scoparone group is 60 percent, and the total effective rate is 90 percent; the cure rate and the total effective rate of the 4-methoxy-2H-chromene-2-one group are obviously improved compared with the scoparone group; the cure rate of the ivermectin group is 93.33%, the total effective rate is 100%, the ivermectin is a known effective medicament for treating animal ectoparasites in the field, the 4-methoxy-2H-chromene-2-one group protected by the invention obtains a curative effect equivalent to that of the animal ectoparasites when treating the animal ectoparasites, meanwhile, the commercially available ivermectin is injected and administered, and the administration is complex, while the 4-methoxycoumarin claimed by the invention is prepared into powder, injection, external ointment, emulsion, spray and the like, so that the administration is convenient.
TABLE 3 curative effect of different drugs on rabbit acariasis
In conclusion, the 4-methoxy-2H-chromen-2-one claimed by the invention has high lethality to the young ticks pernicious, can kill other parasites including the young ticks pernicious, such as fleas, lice, flies, mosquitoes and the like, and meanwhile, the cure rate of the 4-methoxy-2H-chromen-2-one claimed by the invention to the rabbit acariasis is equivalent to that of ivermectin, and can be applied to the preparation of medicaments for treating animal ectoparasites.
Finally, it should be noted that: the above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention, and it will be obvious to those skilled in the art that modifications may be made in the technical solutions described in the above embodiments, or some technical features may be equivalently replaced. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911304065.4A CN112402414B (en) | 2019-12-17 | 2019-12-17 | Medicine for preventing and treating animal ectoparasitosis and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911304065.4A CN112402414B (en) | 2019-12-17 | 2019-12-17 | Medicine for preventing and treating animal ectoparasitosis and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112402414A CN112402414A (en) | 2021-02-26 |
| CN112402414B true CN112402414B (en) | 2022-03-22 |
Family
ID=74844004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911304065.4A Active CN112402414B (en) | 2019-12-17 | 2019-12-17 | Medicine for preventing and treating animal ectoparasitosis and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112402414B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001003681A3 (en) * | 1999-07-08 | 2002-05-10 | Patrick T Prendergast | Use of flavones, coumarins and related compounds to treat infections |
| CN101836955A (en) * | 2010-05-14 | 2010-09-22 | 西北农林科技大学 | Hymecromone microemulsion medicament and preparation method thereof |
| CN103494807A (en) * | 2013-09-30 | 2014-01-08 | 西北农林科技大学 | Efficient acarid-killing medicine and preparation method thereof |
| CN105837545A (en) * | 2016-04-01 | 2016-08-10 | 西北农林科技大学 | Coumarin derivatives containing halogen or benzimidazolyl functional group, and preparation method and application thereof |
| CN109819985A (en) * | 2019-01-22 | 2019-05-31 | 西南大学 | A kind of artemisia lactone emulsifiable concentrate acaricide and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6893652B2 (en) * | 2001-08-27 | 2005-05-17 | Wyeth | Endoparasiticidal gel composition |
-
2019
- 2019-12-17 CN CN201911304065.4A patent/CN112402414B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001003681A3 (en) * | 1999-07-08 | 2002-05-10 | Patrick T Prendergast | Use of flavones, coumarins and related compounds to treat infections |
| CN101836955A (en) * | 2010-05-14 | 2010-09-22 | 西北农林科技大学 | Hymecromone microemulsion medicament and preparation method thereof |
| CN103494807A (en) * | 2013-09-30 | 2014-01-08 | 西北农林科技大学 | Efficient acarid-killing medicine and preparation method thereof |
| CN105837545A (en) * | 2016-04-01 | 2016-08-10 | 西北农林科技大学 | Coumarin derivatives containing halogen or benzimidazolyl functional group, and preparation method and application thereof |
| CN109819985A (en) * | 2019-01-22 | 2019-05-31 | 西南大学 | A kind of artemisia lactone emulsifiable concentrate acaricide and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| "3D-QSAR and Molecular Docking Studies on the TcPMCA1-Mediated Detoxification of Scopoletin and Coumarin Derivatives";Qiu-Li Hou等;《Int. J. Mol. Sci.》;20170627;第18卷(第7期);参见表2 * |
| "Acaricidal Activity of Tonka Bean Extracts. Synthesis and Structure−Activity Relationships of Bioactive Derivatives";Christophe Gleye等;《J. Nat. Prod.》;20030506;第66卷(第5期);参见表1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112402414A (en) | 2021-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112402414B (en) | Medicine for preventing and treating animal ectoparasitosis and application thereof | |
| CN102860310A (en) | Synergistic insecticidal composition used for preventing and curing icerya purchasi maskell | |
| CN110731340B (en) | A kind of drug synergist for preventing and controlling armyworm and using method thereof | |
| JP2013542737A (en) | Methods for inhibiting insect invasion | |
| CN102484994A (en) | Synergistic combination of matrine and chlorantraniliprole | |
| CN112568224B (en) | Insecticidal composition containing chlorfenapyr flubendiamide and diafenthiuron | |
| CN115317498B (en) | Compound drop for treating canine and feline parasites and fungal skin diseases and preparation method thereof | |
| KR101789736B1 (en) | Composition containg ivermectin for Exterminating Clavinema mariae Infection | |
| KR100379026B1 (en) | Method for exterminating scutica in a cultivated flounder | |
| MX2013001039A (en) | Compositions for controlling heartworm infestation. | |
| CN116350623A (en) | Application of epicatechin gallate in the preparation of medicines for preventing and controlling fish melon worm disease | |
| CN111265538B (en) | Application of periplocin in preparing medicine for killing fish ectoparasite | |
| CN108402061B (en) | Biopesticide composition for preventing and treating tea geometrid | |
| CN101305727B (en) | A kind of high-efficiency insecticide composition containing abamectin and profenofos | |
| CN111714502B (en) | Application of solasodine in preparing medicine for killing fish ectoparasite | |
| CN113768970A (en) | Application of rosemary extract in preparation of medicine for preventing and controlling ichthyophthiriasis | |
| CN106234370A (en) | A kind of containing benzo alkene fluorine bacterium azoles and the bactericidal composition of osthole | |
| CN101322492A (en) | A kind of pesticide for controlling rice bakanae disease and blight | |
| CN105343879A (en) | Nematode-trapping fungus and vermifuge combined medication box and its application | |
| CN100356851C (en) | Fructus cnidii thuricin complex insecticide | |
| CN112400908B (en) | A kind of pharmaceutical composition for preventing and treating rhinoceros beetle | |
| CN113768908B (en) | Application of benserazide in preparation of anti-animal acariasis medicine | |
| CN108887284A (en) | A kind of Pesticidal combination containing imidaclothiz and matrine and its application | |
| CN108295119A (en) | Special pest repellant of a kind of largemouth bass cultivation and preparation method thereof | |
| CN111213662B (en) | Insecticidal composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |